The Consultancy Team
PharmaVentures' Consultancy team has a broad range of experiences covering multiple sectors of the pharmaceutical and biotechnology industries.
Tibor Papp MD PhD MBA (Head of Consulting)
Tibor has been involved in some of the most critical issues of the industry including decline of pipeline productivity, managing the mature product portfolio, funding of early stage R&D compounds, responding to new regulatory challenges, globalisation and maximising the value of alliances.
Scott Gorman, PhD MBA (VP Business Development)
Scott has worked internationally with scores of established and emerging pharmaceutical companies in all therapeutic areas providing bespoke advice on strategy, planning, business and market evaluations, product and technology valuations, due diligence including Expert’s Reports for IPOs, partnering/negotiation and litigation support. Scott is also a director of PharmaVentures’ Negotiating Workshops, lecturing at and leading workshop discussions. Formerly, Scott was with Cobra Therapeutics and Wellcome (now GlaxoSmithKline). Scott earned his BS (hons) from the University of Kentucky, his PhD from the University of Pennsylvania and his MBA from Warwick University.
Kevin Bottomley, BSc. (Hons) (Senior Principal)
Kevin has over 25 years of experience in pharmaceutical and biotechnology companies involving senior positions in research, alliance management and business development. He has extensive research and pharmaceutical business development experience, gained at Roche, Quintiles, Hoechst (Sanofi-Aventis) and from 2001 to 2006 was a Senior Director of Business Development in Inpharmatica. Kevin has a degree in Pharmacology from Kings College, University of London.
John Janes BSc(Hons) MA (Managing Consultant)
John has over 25 years experience in the healthcare sector, and has worked for the NHS, and for diagnostics, pharmaceutical and pharma service companies.